Interaction between lncRNAs and RNA-binding proteins (RBPs) influences DNA damage response in cancer chemoresistance
- PMID: 38366290
- DOI: 10.1007/s11033-024-09288-w
Interaction between lncRNAs and RNA-binding proteins (RBPs) influences DNA damage response in cancer chemoresistance
Abstract
The DNA damage response (DDR) is a crucial cellular signaling pathway activated in response to DNA damage, including damage caused by chemotherapy. Chemoresistance, which refers to the resistance of cancer cells to the effects of chemotherapy, poses a significant challenge in cancer treatment. Understanding the relationship between DDR and chemoresistance is vital for devising strategies to overcome this resistance and improve treatment outcomes. Long non-coding RNAs (lncRNAs) are a class of RNA molecules that do not code for proteins but play important roles in various biological processes, including cancer development and chemoresistance. RNA-binding proteins (RBPs) are a group of proteins that bind to RNA molecules and regulate their functions. The interaction between lncRNAs and RBPs has been found to regulate gene expression at the post-transcriptional level, thereby influencing various cellular processes, including DDR signaling pathways. Multiple studies have demonstrated that lncRNAs can interact with RBPs to modulate the expression of genes involved in cancer chemoresistance by impacting DDR signaling pathways. Conversely, RBPs can regulate the expression and function of lncRNAs involved in DDR. Exploring these interactions can provide valuable insights for the development of innovative therapeutic approaches to overcome chemoresistance in cancer patients. This review article aims to summarize recent research on the interaction between lncRNAs and RBPs during cancer chemotherapy, with a specific focus on DDR pathways.
Keywords: Cancer; Chemoresistance; DNA damage response (DDR); Long non-coding RNAs (lncRNAs); RNA-binding proteins (RBPs).
© 2024. The Author(s), under exclusive licence to Springer Nature B.V.
Similar articles
-
Advances in the role of long non‑coding RNAs and RNA‑binding proteins in regulating DNA damage repair in cancer cells.Int J Mol Med. 2023 Oct;52(4):93. doi: 10.3892/ijmm.2023.5296. Epub 2023 Aug 24. Int J Mol Med. 2023. PMID: 37615162 Review.
-
Noncoding RNAs in DNA Damage Response: Opportunities for Cancer Therapeutics.Methods Mol Biol. 2018;1699:3-21. doi: 10.1007/978-1-4939-7435-1_1. Methods Mol Biol. 2018. PMID: 29086365
-
LncRNAs and their RBPs: How to influence the fate of stem cells?Stem Cell Res Ther. 2022 May 3;13(1):175. doi: 10.1186/s13287-022-02851-x. Stem Cell Res Ther. 2022. PMID: 35505438 Free PMC article. Review.
-
New insights into the interplay between long non-coding RNAs and RNA-binding proteins in cancer.Cancer Commun (Lond). 2022 Feb;42(2):117-140. doi: 10.1002/cac2.12254. Epub 2022 Jan 12. Cancer Commun (Lond). 2022. PMID: 35019235 Free PMC article. Review.
-
Interactions between long non‑coding RNAs and RNA‑binding proteins in cancer (Review).Oncol Rep. 2021 Dec;46(6):256. doi: 10.3892/or.2021.8207. Epub 2021 Oct 22. Oncol Rep. 2021. PMID: 34676873 Free PMC article. Review.
Cited by
-
hnRNPH1: A Multifaceted Regulator in RNA Processing and Disease Pathogenesis.Int J Mol Sci. 2025 May 28;26(11):5159. doi: 10.3390/ijms26115159. Int J Mol Sci. 2025. PMID: 40507967 Free PMC article. Review.
-
Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance.Signal Transduct Target Ther. 2025 Jul 18;10(1):219. doi: 10.1038/s41392-025-02266-z. Signal Transduct Target Ther. 2025. PMID: 40675967 Free PMC article. Review.
-
Macrophage polarization in hepatocellular carcinoma: a lncRNA-centric perspective on tumor progression and metastasis.Clin Exp Med. 2025 May 25;25(1):173. doi: 10.1007/s10238-025-01711-1. Clin Exp Med. 2025. PMID: 40413657 Free PMC article. Review.
References
-
- Su M, Wang H, Wang W, Wang Y, Ouyang L, Pan C et al (2018) LncRNAs in DNA damage response and repair in cancer cells. Acta Biochim Biophys Sin 50(5):433–439 - PubMed
-
- Adriaens C, Standaert L, Barra J, Latil M, Verfaillie A, Kalev P et al (2016) p53 induces formation of NEAT1 lncRNA-containing paraspeckles that modulate replication stress response and chemosensitivity. Nat Med 22(8):861–868 - PubMed
-
- Özeş AR, Miller DF, Özeş ON, Fang F, Liu Y, Matei D et al (2016) NF-κB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer. Oncogene 35(41):5350–5361 - PMC
-
- Xiao H, Liu Y, Liang P, Wang B, Tan H, Zhang Y et al (2018) TP53TG1 enhances cisplatin sensitivity of non-small cell lung cancer cells through regulating miR-18a/PTEN axis. Cell Biosci 8(1):1–13
-
- Astanehe A, Finkbeiner M, Hojabrpour P, To K, Fotovati A, Shadeo A et al (2009) The transcriptional induction of PIK3CA in tumor cells is dependent on the oncoprotein Y-box binding protein-1. Oncogene 28(25):2406–2418 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical